Marius A Øvrehus

Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria

S. Hallan, P. Zürbig, M. A. Øvrehus, 2015, Clinical Proteomics.

Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.

S. Hallan, J. Ix, A. Langhammer, 2016, Kidney international.

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis

I. D. de Boer, W. Ju, S. Hallan, 2018, Kidney international reports.

Hypertensive nephrosclerosis: wider kidney biopsy indications may be needed to improve diagnostics

S. Hallan, J. Ix, A. Fogo, 2020, Journal of internal medicine.

Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria

S. Hallan, P. Zürbig, M. A. Øvrehus, 2015, Clinical Proteomics.